阿卡迪亞製藥公司
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership836,510 shares
Latest Disclosed Value $ 18,620,713
Invesco Ltd. reports 1.35% decrease in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 836,510 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $18,620,713 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 847,961 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -1.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 836,510 -11,451 -1.35 18,621 -17.79 0.0029
2026-02-19 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 847,961 107,386 14.50 22,649 43.32 0.0035
2025-11-13 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 740,575 -117,405 -13.68 15,804 -14.61 0.0025
2025-08-13 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 857,980 126,404 17.28 18,507 52.30 0.0031
2025-05-12 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 731,576 219,256 42.80 12,151 29.25 0.0023
2025-02-13 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 512,320 -45,744 -8.20 9,401 9.53 0.0017
2024-11-12 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 558,064 472,640 553.29 8,583 518.37 0.0017
2024-08-13 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 85,424 -264,963 -75.62 1,388 -78.57 0.0003
2024-05-14 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 350,387 -72,582 -17.16 6,479 -51.08 0.0014
2024-02-13 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 422,969 89,997 27.03 13,243 90.85 0.0032
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 332,972 -64,548 -16.24 6,939 -27.11 0.0019
2023-08-11 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 397,520 -76,450 -16.13 9,521 6.73 0.0025
2023-05-12 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 473,970 -61,774 -11.53 8,920 4.58 0.0025
2023-02-13 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 535,744 54,824 11.40 8,529 8.40 0.0025
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 480,920 31,226 6.94 7,868 24.18 0.0025
2022-08-15 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 449,694 -26,172 -5.50 6,336 -45.02 0.0019
2022-05-16 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 475,866 409,120 612.95 11,525 639.73 0.0029
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 66,746 -4,796 -6.70 1,558 31.14 0.0004
2021-11-15 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 71,542 8,626 13.71 1,188 -22.61 0.0003
2021-08-17 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 62,916 -4,525 -6.71 1,535 -11.73 0.0004
2021-05-17 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 67,441 -1,125,174 -94.35 1,739 -97.27 0.0005
2021-02-16 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,192,615 891,392 295.92 63,757 413.13 0.0186
2020-11-16 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 301,223 -3,871 -1.27 12,425 -15.98 0.0042
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 305,094 -268,532 -46.81 14,788 -38.98 0.0053
2020-05-15 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 573,626 -950,634 -62.37 24,235 -62.83 0.0102
2020-02-14 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,524,260 -2,587,265 -62.93 65,208 -55.93 0.0202
2019-11-14 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,111,525 96,043 2.39 147,973 37.86 0.0387
2019-08-14 2019-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 4,015,482 3,633,171 950.32 107,334 945.63 0.0276
2019-08-14 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,015,482 3,500,859 107,334
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 382,311 -129,476 -25.30 10,265 24.03 0.0035
2019-02-14 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 511,787 -3,377 -0.66 8,276 -22.62 0.0032
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 515,164 219,261 74.10 10,695 136.67 0.0034
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 295,903 -6,335 -2.10 4,519 -33.46 0.0015
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 302,238 -1,467,176 -82.92 6,791 -87.25 0.0025
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,769,414 -224,853 -11.27 53,277 -29.08 0.0192
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,994,267 608 0.03 75,125 35.11 0.0277
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,993,659 346,706 21.05 55,603 -1.80 0.0173
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,646,953 479,003 41.01 56,623 68.11 0.0186
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,167,950 4,080 0.35 33,683 -9.02 0.0113
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,163,870 10,603 0.92 37,023 -1.10 0.0127
2016-08-15 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,153,267 2,824 0.25 37,436 16.38 0.0138
2016-05-16 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,150,443 -116,152 -9.17 32,166 -28.76 0.0131
2016-02-16 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,266,595 22,070 1.77 45,154 9.71 0.0180
2015-11-16 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,244,525 -88,411 -6.63 41,157 -26.27 0.0175
2015-08-14 2015-06-30 13F ACADIA PHARMACEUTICALS COMMON 004225108 1,332,936 861,555 182.77 55,823 263.36 0.0219
2015-05-15 2015-03-31 13F ACADIA PHARMACEUTICALS COMMON 004225108 471,381 13,851 3.03 15,363 5.75 0.0059
2015-02-13 2014-12-31 13F ACADIA PHARMACEUTICALS COMMON 004225108 457,530 0 0.00 14,527 28.24 0.0056
2014-11-14 2014-09-30 13F ACADIA PHARMACEUTICALS COMMON 004225108 457,530 0 0.00 11,328 9.60 0.0045
2014-08-14 2014-06-30 13F ACADIA PHARMACEUTICALS COMMON 004225108 457,530 -717,536 -61.06 10,336 -63.85 0.0041
2014-05-15 2014-03-31 13F ACADIA PHARMACEUTICALS COMMON 004225108 1,175,066 734,723 166.85 28,589 159.81 0.0116
2014-02-13 2013-12-31 13F ACADIA PHARMACEUTICALS COMMON 004225108 440,343 -463,802 -51.30 11,004 -55.70 0.0044
2013-11-13 2013-09-30 13F ACADIA PHARMACEUTICALS COMMON 004225108 904,145 343,333 61.22 24,837 144.00 0.0108
2013-08-14 2013-06-30 13F ACADIA PHARMACEUTICALS COMMON 004225108 560,812 560,812 10,179 0.0047
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.